Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease

Haruki Takikawa1, Ryusuke Ae2, Yuri Matsubara1

  • 1Division of Public Health, Center for Community Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Insights

Redness and crusting at the bacille Calmette-Guérin inoculation site (BCGitis) during Kawasaki disease (KD) is not an independent risk factor for cardiac complications. Prompt intravenous immunoglobulin (IVIG) treatment appears to be a confounding factor, potentially preventing these complications.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Cardiology

Background:

  • Kawasaki disease (KD) is a critical pediatric illness.
  • Cardiac complications are a major concern in KD patients.
  • Bacille Calmette-Guérin inoculation site inflammation (BCGitis) is observed in some KD cases.

Purpose of the Study:

  • To determine if BCGitis is an independent risk factor for cardiac complications in Kawasaki disease.
  • To investigate the relationship between BCGitis and the development of cardiac sequelae in KD patients.

Main Methods:

  • Retrospective cohort study utilizing nationwide Kawasaki disease survey data from Japan (2005-2006).
  • Inclusion of 17,181 pediatric patients diagnosed with KD.
  • Analysis of BCGitis presence and its association with cardiac complications, adjusting for treatment factors.

Main Results:

  • BCGitis was present in 44% of KD patients.
  • Initially, BCGitis appeared associated with fewer cardiac complications (crude OR 0.81).
  • After adjusting for early intravenous immunoglobulin (IVIG) treatment, BCGitis was not an independent risk factor (adjusted OR 0.89).

Conclusions:

  • BCGitis is not an independent predictor of cardiac complications in Kawasaki disease.
  • Early administration of IVIG is a significant factor, potentially confounding the association with BCGitis.
  • Prompt treatment may mitigate the risk of cardiac complications, regardless of BCGitis presence.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
222
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
197
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
82
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
108
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
161
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
181